Pancreatic Cancer Research

ResearcherJesse Brown VA Medical CenterActive in the last 2 years

Daniela E Matei

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0003-2169-5035; OpenAlex author ID A5067743297; NIH RePORTER profile ID 6681816. Sources: OpenAlex.

Their work

Papers
2 (first author 0, last author 2)
Trials
0
Grants
2
Labs led
1
Collaborators
4
Papers, trials and grants by year

2012: 1 grant · 2013: none · 2014: none · 2015: 1 paper · 2016: 1 paper · 2017: none · 2018: none · 2019: none · 2020: none · 2021: none · 2022: none · 2023: none · 2024: none · 2025: none · 2026: 1 grant

Papers 2

  1. Tissue Transglutaminase Activates Cancer-Associated Fibroblasts and Contributes to Gemcitabine Resistance in Pancreatic Cancer. Last author DOI 10.1016/j.neo.2016.09.003↗
  2. Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression. Last author DOI 10.1158/1078-0432.ccr-15-0226↗

Grants 2

  1. Northwestern University Lead Academic Participating Site UG1CA308665↗
  2. Transglutaminase Modulated Tumor-Stroma Interaction in Pancreatic Cancer R21CA152502↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. Al B. Benson · 1 shared grant, 2026 · strength 1.26
  2. Jiyoon Lee · 2 shared papers, 2015–2016 · strength 0.11
  3. Melissa L. Fishel · 1 shared paper, 2016 · strength 0.06
  4. Jingwu Xie · 1 shared paper, 2015 · strength 0.05

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.